Preoperative Assessment and Identification of Concurrent Metastases in Colorectal Cancer: The Impact of CECT and Clinical Features - Scorecard - MDSpire

Preoperative Assessment and Identification of Concurrent Metastases in Colorectal Cancer: The Impact of CECT and Clinical Features

  • By

  • Yinfei Fan

  • Ruidan Yang

  • Yue Shu

  • Wenjun Xie

  • Xiaopeng He

  • Jiong Liu

  • Jian Shu

  • November 12, 2025

  • 0 min

Share

Clinical Scorecard: Preoperative Assessment and Identification of Concurrent Metastases in Colorectal Cancer: The Impact of CECT and Clinical Features

At a Glance

CategoryDetail
ConditionColorectal Cancer (CC)
Key MechanismsAccumulation of genetic alterations leading to tumor progression and metastasis.
Target PopulationPatients with histopathologically confirmed colon cancer, aged 18 and older.
Care SettingRetrospective single-centre study in a surgical setting.

Key Highlights

  • Approximately 20%-25% of CC patients present with synchronous metastases at diagnosis.
  • Surgical resection remains a key therapeutic strategy, with only 25% of patients with liver metastases eligible for surgery.
  • CECT is recommended as the preferred preoperative imaging modality for assessing CC and its metastases.

Guideline-Based Recommendations

Diagnosis

  • Use CECT for preoperative assessment of colon cancer and detection of distant metastases.

Management

  • Surgical intervention is preferred for synchronous lung metastases over chemotherapy alone.

Monitoring & Follow-up

  • Monitor clinical characteristics such as age, gender, BMI, CEA, and CA19-9 levels for predicting metastasis risk.

Risks

  • Metastases serve as independent prognostic factors for poor survival in patients not undergoing chemotherapy.

Patient & Prescribing Data

Patients with confirmed colon cancer undergoing surgical resection.

Early detection of synchronous metastases is critical for improving patient outcomes.

Clinical Best Practices

  • Utilize multi-phase CECT for optimal characterization of primary tumors and detection of metastases.
  • Ensure comprehensive clinical data collection for personalized treatment planning.

References

Original Source(s)

Related Content